Clinical trial
Pentoxifylline as a New Adjuvant in Adult Patients With Major Depressive Disorder: Randomized, Double Blind, Placebo Controlled Trial.
NCT03554447 is registered in ClinicalTrials.gov with Mahmoud Samy Abdallah as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pentoxifylline as a New Adjuvant in Adult Patients With Major Depressive Disorder: Randomized, Double Blind, Placebo Controlled Trial.
- Lead sponsor
- Mahmoud Samy Abdallah
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 20, 2015
- Completion date
- December 31, 2018
- Enrollment
- 80 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.